Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | UCART123 |
| Trade Name | |
| Synonyms | UCART-123|UCART 123|Universal CAR123-expressing T-lymphocytes |
| Drug Descriptions |
UCART123 are allogeneic T-cells that contain a chimeric antigen receptor (CAR) targeting CD123 (IL3RA) and an RQR8 depletion ligand, which potentially induce cytotoxicity in cells expressing CD123 (ASH Meeting, 2016, abstract nr 4039, PMID: 31360087). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C146806 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| UCART123 | UCART123 | 0 | 2 |